The No. 2 in command at the National Institutes of Health, Dr. Lawrence A. Tabak, who served as acting director of the agency ...
The planned $4 billion cut in funding for scientific inquiry to the nation’s universities and academic medical institutions ...
Dr. Lawrence Tabak, the No. 2 official at the National Institutes of Health, did not give a reason for his departure.
The Department of Health and Human Services (HHS) canceled more than $180 million in contracts over 48 hours, including a ...
Eating gradually increasing doses of store-bought, home-measured peanut butter for about 18 months enabled 100% of children with peanut allergy who initially could tolerate the equivalent of at least ...
The phase 2 CAFETERIA study included participants aged 4 to 14 years who were able to tolerate at least 143mg of peanut protein.
Children with high-threshold peanut allergies showed incredible improvements after undergoing an 18-month program using store ...
News Medical on MSN3d
NIH clinical trial examines investigational therapy for dengueA clinical trial supported by the National Institutes of Health (NIH) is testing an experimental treatment designed to help people suffering the effects of dengue, a mosquito-borne viral disease.
Findings suggest a safe, inexpensive, and effective pathway for allergists to treat children who already tolerate at least half a peanut.
Children with high-threshold peanut allergy who ate gradually larger doses of store-bought peanut butter achieved ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback